GlaxoSmithKline Pharma q3 net declines 72%

​​Total income increased to ₹833 crore for the third quarter of the current fiscal as compared with ₹826 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a statement.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news